...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The Journal of Technology Transfer >Basic science as a prescription for breakthrough inventions in the pharmaceutical industry
【24h】

Basic science as a prescription for breakthrough inventions in the pharmaceutical industry

机译：基础科学作为制药行业突破性发明的处方

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

This analysis contributes to the understanding of the role of basic science in generating breakthrough inventions in the pharmaceutical industry. Recognizing the within-firm heterogeneity of inventive activities, we look not only at the firm level, but also at the firm-technology level for characteristics determining breakthroughs. A key finding is that firms pursuing basic science are more likely to produce breakthrough inventions. At the same time, doing more basic science in science disciplines that are closely linked to a given technology domain does not increase the likelihood of BTs in that particular technology. The insignificance of basic science intensity at the technology level, coupled to the significance at the firm level, suggests that the breakthrough rewards from science capacity are not reaped in the technology areas immediately involved in basic science, but in other areas of the technology portfolio of the firm. Our findings are consistent with the view of science as a map to span processes of local search and the wider applicability of scientific insights.
机译：该分析有助于理解基础科学在制药行业中产生突破性发明的作用。认识到发明活动在公司内部的异质性，我们不仅在公司层面，而且在公司技术层面上寻找确定突破的特征。一个关键发现是，追求基础科学的公司更有可能产生突破性的发明。同时，在与给定技术领域密切相关的科学学科中做更多的基础科学，不会增加特定技术中BT的可能性。技术层面上基础科学强度的微不足道，再加上企业层面上的重要性，表明科学能力的突破性回报并不是在直接参与基础科学的技术领域中获得的，而是在技术组合的其他领域中获得的。该公司。我们的发现与科学作为跨越本地搜索过程的地图以及科学见解的广泛适用性相一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号